Muscle Memory.
Highly skilled typists actually have trouble identifying positions of many of the keys on a footing QWERTY keyboard, researchers say, suggesting there's much more to typing than routine learning. The new study "demonstrates that we're capable of doing extremely complicated things without knowledgeable explicitly what we are doing," lead researcher Kristy Snyder, a Vanderbilt University mark student, said in a university news release. She and her colleagues asked 100 males and females to complete a short typing test.
They were then shown a blank keyboard and given 80 seconds to write the letters within the exact keys. On average, these participants were proficient typists, banging out 72 words per write down with 94 percent accuracy. However, when quizzed, they could accurately place an regular of only 15 letters on the blank keyboard, according to the study published in the journal Attention, Perception, andamp; Psychophysics.
Tuesday, 26 November 2019
Saturday, 23 November 2019
Doctors Told About The New Flu
Doctors Told About The New Flu.
This year's flu mellow may be off to a somnolent start nationwide, but infection rates are spiking in the south-central United States, where five deaths have already been reported in Texas. And the controlling strain of flu so far has been H1N1 "swine" flu, which triggered the pandemic flu in 2009, federal salubriousness officials said. "That may change, but uprightness now most of the flu is H1N1," said Dr Michael Young, a medical catchpole with the US Centers for Disease Control and Prevention's influenza division. "It's the same H1N1 we have been light of the past couple of years and that we really started to see in 2009 during the pandemic".
States reporting increasing levels of flu movement include Alabama, Louisiana, Mississippi and Texas. Young eminent that H1N1 flu is different from other types of flu because it tends to strike younger adults harder than older adults. Flu is typically a bigger portent to people 65 and older and very junior children and people with chronic medical conditions, such as heart disease and diabetes. This year, because it's an H1N1 mature so far, we are seeing more infections in younger adults".
So "And some of these folks have underlying conditions that put them at peril for hospitalization or death. This may be surprising to some folks, because they forget the citizens that H1N1 hits". The good news is that this year's flu vaccine protects against the H1N1 flu. "For citizenry who aren't vaccinated yet, there's still time - they should go out and get their vaccine," he advised.
This year's flu mellow may be off to a somnolent start nationwide, but infection rates are spiking in the south-central United States, where five deaths have already been reported in Texas. And the controlling strain of flu so far has been H1N1 "swine" flu, which triggered the pandemic flu in 2009, federal salubriousness officials said. "That may change, but uprightness now most of the flu is H1N1," said Dr Michael Young, a medical catchpole with the US Centers for Disease Control and Prevention's influenza division. "It's the same H1N1 we have been light of the past couple of years and that we really started to see in 2009 during the pandemic".
States reporting increasing levels of flu movement include Alabama, Louisiana, Mississippi and Texas. Young eminent that H1N1 flu is different from other types of flu because it tends to strike younger adults harder than older adults. Flu is typically a bigger portent to people 65 and older and very junior children and people with chronic medical conditions, such as heart disease and diabetes. This year, because it's an H1N1 mature so far, we are seeing more infections in younger adults".
So "And some of these folks have underlying conditions that put them at peril for hospitalization or death. This may be surprising to some folks, because they forget the citizens that H1N1 hits". The good news is that this year's flu vaccine protects against the H1N1 flu. "For citizenry who aren't vaccinated yet, there's still time - they should go out and get their vaccine," he advised.
Thursday, 21 November 2019
Another Type Of Congenital Heart Disease May Be Cured By The Device And The Surgery
Another Type Of Congenital Heart Disease May Be Cured By The Device And The Surgery.
A congenital verve shortfall that was typically catastrophic three decades ago is no longer so deadly, thanks to new technologies and surgical techniques that admit babies to survive well into adulthood, researchers report. A study in the May 27 dissemination of the New England Journal of Medicine compares the effectiveness of older and newer versions of devices aimed at fixing incompletely formed hearts. The writing-room finds both performing equally well over three years.
It's a "landmark" study, "one that we've never had before in congenital hub disease," said Dr Gail D Pearson, kingpin of the Adult and Pediatric Cardiac Research Program at the US National Heart, Lung and Blood Institute, which financed the effort. The study, which compared two devices for keeping oxygen-carrying blood flowing in 549 children born with hearts incapable of doing it alone, has not yet produced exhaustive results favoring one stratagem over the other.
But the probing is indeed just beginning. "Continuing follow-up will help us sort out the near- and long-term results". Study architect Dr Richard G Ohye, head of the University of Michigan pediatric cardiovascular surgery division, agreed. "Well be able to follow them to adulthood, and they will teach us about the best way to rule them". The children in the study were born with hearts that had a nonfunctioning - or nonexistent - hand ventricle, the chamber that pumps blood to the body. About 1000 such children are born in the United States each year, one in 5000.
A congenital verve shortfall that was typically catastrophic three decades ago is no longer so deadly, thanks to new technologies and surgical techniques that admit babies to survive well into adulthood, researchers report. A study in the May 27 dissemination of the New England Journal of Medicine compares the effectiveness of older and newer versions of devices aimed at fixing incompletely formed hearts. The writing-room finds both performing equally well over three years.
It's a "landmark" study, "one that we've never had before in congenital hub disease," said Dr Gail D Pearson, kingpin of the Adult and Pediatric Cardiac Research Program at the US National Heart, Lung and Blood Institute, which financed the effort. The study, which compared two devices for keeping oxygen-carrying blood flowing in 549 children born with hearts incapable of doing it alone, has not yet produced exhaustive results favoring one stratagem over the other.
But the probing is indeed just beginning. "Continuing follow-up will help us sort out the near- and long-term results". Study architect Dr Richard G Ohye, head of the University of Michigan pediatric cardiovascular surgery division, agreed. "Well be able to follow them to adulthood, and they will teach us about the best way to rule them". The children in the study were born with hearts that had a nonfunctioning - or nonexistent - hand ventricle, the chamber that pumps blood to the body. About 1000 such children are born in the United States each year, one in 5000.
Wednesday, 20 November 2019
Risk Factors For Alzheimer's Disease
Risk Factors For Alzheimer's Disease.
Older adults with homage problems and a narration of concussion have more buildup of Alzheimer's disease-associated plaques in the brain than those who also had concussions but don't have respect problems, according to a new study. "What we think it suggests is, head trauma is associated with Alzheimer's-type dementia - it's a endanger factor," said study researcher Michelle Mielke, an friend professor of epidemiology and neurology at Mayo Clinic Rochester. But it doesn't degenerate someone with head trauma is automatically going to develop Alzheimer's. Her turn over is published online Dec 26, 2013 and in the Jan 7, 2014 print version of the journal Neurology.
Previous studies looking at whether head trauma is a risk factor for Alzheimer's have come up with conflicting results. And Mielke stressed that she has found only a relate or association, not a cause-and-effect relationship. In the study, Mielke and her band evaluated 448 residents of Olmsted County, Minn, who had no signs of tribute problems.
They also evaluated another 141 residents with memory and thinking problems known as mild cognitive impairment. More than 5 million Americans have Alzheimer's disease, according to the Alzheimer's Association. Plaques are deposits of a protein scrap known as beta-amyloid that can erect up in between the brain's nerve cells. While most folk develop some with age, those who develop Alzheimer's generally get many more, according to the Alzheimer's Association.
They also minister to to get them in a predictable pattern, starting in brain areas crucial for memory. In the Mayo study, all participants were venerable 70 or older. The participants reported if they ever had a brain injury that implicated loss of consciousness or memory. Of the 448 without any memory problems, 17 percent had reported a cognition injury. Of the 141 with memory problems, 18 percent did.
Older adults with homage problems and a narration of concussion have more buildup of Alzheimer's disease-associated plaques in the brain than those who also had concussions but don't have respect problems, according to a new study. "What we think it suggests is, head trauma is associated with Alzheimer's-type dementia - it's a endanger factor," said study researcher Michelle Mielke, an friend professor of epidemiology and neurology at Mayo Clinic Rochester. But it doesn't degenerate someone with head trauma is automatically going to develop Alzheimer's. Her turn over is published online Dec 26, 2013 and in the Jan 7, 2014 print version of the journal Neurology.
Previous studies looking at whether head trauma is a risk factor for Alzheimer's have come up with conflicting results. And Mielke stressed that she has found only a relate or association, not a cause-and-effect relationship. In the study, Mielke and her band evaluated 448 residents of Olmsted County, Minn, who had no signs of tribute problems.
They also evaluated another 141 residents with memory and thinking problems known as mild cognitive impairment. More than 5 million Americans have Alzheimer's disease, according to the Alzheimer's Association. Plaques are deposits of a protein scrap known as beta-amyloid that can erect up in between the brain's nerve cells. While most folk develop some with age, those who develop Alzheimer's generally get many more, according to the Alzheimer's Association.
They also minister to to get them in a predictable pattern, starting in brain areas crucial for memory. In the Mayo study, all participants were venerable 70 or older. The participants reported if they ever had a brain injury that implicated loss of consciousness or memory. Of the 448 without any memory problems, 17 percent had reported a cognition injury. Of the 141 with memory problems, 18 percent did.
Certain Medications Is Not Enough In The US
Certain Medications Is Not Enough In The US.
Four out of five doctors who examine cancer were powerless to prescribe their medication of choice at least once during a six-month while because of a drug shortage, according to a new survey. The survey also found that more than 75 percent of oncologists were calculated to make a major change in patient treatment. These changes included altering the regimen of chemotherapy drugs initially prescribed and substituting one of the drugs in a nice chemotherapy regimen. Such changes might not be well studied, and it might not be unquestioned if the substitutions will work as well or be as safe as what the doctor wanted to prescribe, experts say.
And "The drugs we're conjunctio in view of in shortages are for colon cancer, bosom cancer and leukemia," said Dr Keerthi Gogineni, an oncologist who led the team conducting the survey. "These are drugs for forward but curable cancers. These are our bread-and-butter drugs for trite cancers, and they don't necessarily have substitutes. When we asked people how they adapted to the shortages, they either switched combinations of drugs or switched one medicament within a regimen," said Gogineni, of the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania.
So "They're making the best of a nit-picking situation, but, truly, we don't have a pick up of how these substitutions might affect survival outcomes". Results of the survey were published as a inscribe in the Dec 19, 2013 issue of the New England Journal of Medicine. The scrutiny included more than 200 physicians who routinely prescribe cancer drugs. When substitutions have to be made, it's often a generic cure-all that's unavailable. Sixty percent of doctors surveyed reported having to prefer a more expensive brand-name drug to continue treatment in the face of a shortage.
The remainder in cost can be staggering, however. When a generic drug called fluorouracil was unavailable, substituting the brand-name anaesthetize Xeloda was 140 times more expensive than the desired drug, according to the survey. Another choice is to delay treatment, but again it's not clear what effect waiting might have on an individual patient's cancer. Forty-three percent of oncologists delayed curing during a drug shortage, according to the survey.
Complicating matters for doctors is that there are no conventional guidelines for making substitutions. Almost 70 percent of the oncologists surveyed said their cancer center or vocation had no formal guidelines to aid in their decision-making. Generic chemotherapy drugs have been at jeopardy of shortages since 2006, according to background information accompanying the survey results. As many as 70 percent of opiate shortages occur due to a breakdown in production, according to the US Food and Drug Administration.
Four out of five doctors who examine cancer were powerless to prescribe their medication of choice at least once during a six-month while because of a drug shortage, according to a new survey. The survey also found that more than 75 percent of oncologists were calculated to make a major change in patient treatment. These changes included altering the regimen of chemotherapy drugs initially prescribed and substituting one of the drugs in a nice chemotherapy regimen. Such changes might not be well studied, and it might not be unquestioned if the substitutions will work as well or be as safe as what the doctor wanted to prescribe, experts say.
And "The drugs we're conjunctio in view of in shortages are for colon cancer, bosom cancer and leukemia," said Dr Keerthi Gogineni, an oncologist who led the team conducting the survey. "These are drugs for forward but curable cancers. These are our bread-and-butter drugs for trite cancers, and they don't necessarily have substitutes. When we asked people how they adapted to the shortages, they either switched combinations of drugs or switched one medicament within a regimen," said Gogineni, of the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania.
So "They're making the best of a nit-picking situation, but, truly, we don't have a pick up of how these substitutions might affect survival outcomes". Results of the survey were published as a inscribe in the Dec 19, 2013 issue of the New England Journal of Medicine. The scrutiny included more than 200 physicians who routinely prescribe cancer drugs. When substitutions have to be made, it's often a generic cure-all that's unavailable. Sixty percent of doctors surveyed reported having to prefer a more expensive brand-name drug to continue treatment in the face of a shortage.
The remainder in cost can be staggering, however. When a generic drug called fluorouracil was unavailable, substituting the brand-name anaesthetize Xeloda was 140 times more expensive than the desired drug, according to the survey. Another choice is to delay treatment, but again it's not clear what effect waiting might have on an individual patient's cancer. Forty-three percent of oncologists delayed curing during a drug shortage, according to the survey.
Complicating matters for doctors is that there are no conventional guidelines for making substitutions. Almost 70 percent of the oncologists surveyed said their cancer center or vocation had no formal guidelines to aid in their decision-making. Generic chemotherapy drugs have been at jeopardy of shortages since 2006, according to background information accompanying the survey results. As many as 70 percent of opiate shortages occur due to a breakdown in production, according to the US Food and Drug Administration.
Experts Suggest Targeting How To Treat Migraine
Experts Suggest Targeting How To Treat Migraine.
The holidays can call into doubt the estimated 30 million migraine sufferers in the United States as they look over to deal with crowds, fraternize delays, stress and other potential headache triggers. Even if you don't get the debilitating headaches, there's a high-mindedness chance you have loved ones who do. Nearly one in four US households includes someone afflicted with migraines, according to the Migraine Research Foundation. There are a sum of ways to make do with migraines during the holidays, said David Yeomans, director of pain research at the Stanford University School of Medicine Dec 2013.
Along with expert and trying to avoid your migraine triggers, you deprivation to be prepared to deal with a headache. Light sensitivity, changes in sleep patterns, and certain foods and smells - all base migraine triggers - might be harder to avoid during the holiday season. "When you've got kinsmen over or are at a loved one's home, it can be tricky to adjust your normal pattern or routine," Yeomans said in a news release.
The holidays can call into doubt the estimated 30 million migraine sufferers in the United States as they look over to deal with crowds, fraternize delays, stress and other potential headache triggers. Even if you don't get the debilitating headaches, there's a high-mindedness chance you have loved ones who do. Nearly one in four US households includes someone afflicted with migraines, according to the Migraine Research Foundation. There are a sum of ways to make do with migraines during the holidays, said David Yeomans, director of pain research at the Stanford University School of Medicine Dec 2013.
Along with expert and trying to avoid your migraine triggers, you deprivation to be prepared to deal with a headache. Light sensitivity, changes in sleep patterns, and certain foods and smells - all base migraine triggers - might be harder to avoid during the holiday season. "When you've got kinsmen over or are at a loved one's home, it can be tricky to adjust your normal pattern or routine," Yeomans said in a news release.
A New Method To Fight Leukemia
A New Method To Fight Leukemia.
Preliminary probing shows that gene treatment might one day be a powerful weapon against leukemia and other blood cancers. The experiential treatment coaxed certain blood cells into targeting and destroying cancer cells, according to examine presented Dec 2013 at the American Society of Hematology's annual meeting in New Orleans. "It's categorically exciting," Dr Janis Abkowitz, blood diseases chief at the University of Washington in Seattle and president of the American Society of Hematology, told the Associated Press.
And "You can embezzle a chamber that belongs to a patient and engineer it to be an attack cell". At this point, more than 120 patients with unlike types of blood and bone marrow cancers have been given the treatment, according to the wire service, and many have gone into indulgence and stayed in remission up to three years later. In one study, all five adults and 19 of 22 children with shooting lymphocytic leukemia (ALL) were cleared of the cancer. A few have relapsed since the investigation was done.
In another trial, 15 of 32 patients with chronic lymphocytic leukemia (CLL) initially responded to the psychoanalysis and seven have experienced a complete remission of their disease, according to a news unshackle from the trial researchers, who are from the University of Pennsylvania. All the patients in the studies had few options left, the researchers eminent in the news release. Many were ineligible for bone marrow transplantation or did not want that treatment because of the dangers associated with the procedure, which carries at least a 20 percent mortality risk.
Preliminary probing shows that gene treatment might one day be a powerful weapon against leukemia and other blood cancers. The experiential treatment coaxed certain blood cells into targeting and destroying cancer cells, according to examine presented Dec 2013 at the American Society of Hematology's annual meeting in New Orleans. "It's categorically exciting," Dr Janis Abkowitz, blood diseases chief at the University of Washington in Seattle and president of the American Society of Hematology, told the Associated Press.
And "You can embezzle a chamber that belongs to a patient and engineer it to be an attack cell". At this point, more than 120 patients with unlike types of blood and bone marrow cancers have been given the treatment, according to the wire service, and many have gone into indulgence and stayed in remission up to three years later. In one study, all five adults and 19 of 22 children with shooting lymphocytic leukemia (ALL) were cleared of the cancer. A few have relapsed since the investigation was done.
In another trial, 15 of 32 patients with chronic lymphocytic leukemia (CLL) initially responded to the psychoanalysis and seven have experienced a complete remission of their disease, according to a news unshackle from the trial researchers, who are from the University of Pennsylvania. All the patients in the studies had few options left, the researchers eminent in the news release. Many were ineligible for bone marrow transplantation or did not want that treatment because of the dangers associated with the procedure, which carries at least a 20 percent mortality risk.
British Scientists Have Reported That Children Cured Of Childhood Cancer Have A High Risk Of Premature Death
British Scientists Have Reported That Children Cured Of Childhood Cancer Have A High Risk Of Premature Death.
Childhood cancer casts a extensive shadow. Those who persist the fresh cancer are at high risk of at death's door prematurely decades afterward from new cancers, heart disease and stroke likely caused by the cancer care itself, British researchers report. Although more children are surviving cancer, many have long-term risks of fading prematurely from other diseases. These excess deaths, the researchers say, may be kin to late complications of treatment, such as the long-term effects of radiation and chemotherapy.
Equally troubling is that many older survivors are not being monitored for these problems, the researchers added. Compared to the all-inclusive population, excess deaths may follow-up from new primary cancers and circulatory disease that surface up to 45 years after a boyhood cancer diagnosis, said lead researcher Raoul C Reulen of the Center for Childhood Cancer Survivor Studies at the University of Birmingham.
Reulen illustrious that while the risk of death from the effects of changed cancers and cancer treatments increases with age, many of the most vulnerable survivors are not monitored for these life-threatening salubrity problems. "In terms of absolute risk, older survivors are most at risk of dying of a flash primary cancer and circulatory disease, yet are less likely to be on active follow-up. This suggests that survivors should be able to access vigour care intervention programs even many years" after they pass the mark for five-year survival.
The detonation is published in the July 14 issue of the Journal of the American Medical Association. For the study, Reulen's tandem collected data on 17981 children who survived cancer. These children, born between 1940 and 1991, were all diagnosed with a malignancy before they were 15.
By the end of 2006, 3049 of these individuals had died. That was a reproach 11 times higher than would be seen in the non-specific population - something called the usual mortality rate. And while the rate dropped over time, it was still three-fold higher than expected after 45 years of follow-up, the researchers note.
Childhood cancer casts a extensive shadow. Those who persist the fresh cancer are at high risk of at death's door prematurely decades afterward from new cancers, heart disease and stroke likely caused by the cancer care itself, British researchers report. Although more children are surviving cancer, many have long-term risks of fading prematurely from other diseases. These excess deaths, the researchers say, may be kin to late complications of treatment, such as the long-term effects of radiation and chemotherapy.
Equally troubling is that many older survivors are not being monitored for these problems, the researchers added. Compared to the all-inclusive population, excess deaths may follow-up from new primary cancers and circulatory disease that surface up to 45 years after a boyhood cancer diagnosis, said lead researcher Raoul C Reulen of the Center for Childhood Cancer Survivor Studies at the University of Birmingham.
Reulen illustrious that while the risk of death from the effects of changed cancers and cancer treatments increases with age, many of the most vulnerable survivors are not monitored for these life-threatening salubrity problems. "In terms of absolute risk, older survivors are most at risk of dying of a flash primary cancer and circulatory disease, yet are less likely to be on active follow-up. This suggests that survivors should be able to access vigour care intervention programs even many years" after they pass the mark for five-year survival.
The detonation is published in the July 14 issue of the Journal of the American Medical Association. For the study, Reulen's tandem collected data on 17981 children who survived cancer. These children, born between 1940 and 1991, were all diagnosed with a malignancy before they were 15.
By the end of 2006, 3049 of these individuals had died. That was a reproach 11 times higher than would be seen in the non-specific population - something called the usual mortality rate. And while the rate dropped over time, it was still three-fold higher than expected after 45 years of follow-up, the researchers note.
People With Diabetes May Have An Increased Risk Of Cancer
People With Diabetes May Have An Increased Risk Of Cancer.
People with diabetes may have something else to be troubled about - an increased jeopardize of cancer, according to a green consensus report produced by experts recruited jointly by the American Cancer Society and the American Diabetes Association. Diabetes, mostly type 2 diabetes, has been linked to certain cancers, though experts aren't ineluctable if the disease itself leads to the increased risk or if shared risk factors, such as obesity, may be to blame. Other digging has suggested that some diabetes treatments, such as certain insulins, may also be associated with the circumstance of some cancers.
But the evidence isn't conclusive, and it's difficult to tease out whether the insulin is liable for the association or other risk factors associated with diabetes could be the root of the link. "There have been some epidemiological studies that suggest that individuals who are pot-bellied or who have high levels of insulin appear to have an increased prevalence of certain malignancies, but it's a complex edition because the association is not true for all cancers," explained Dr David Harlan, guide of the Diabetes Center of Excellence at the University of Massachusetts Memorial Medical Center in Worcester, and one of the authors of the consensus report. "So, there's some smoke to suggest an linkage - but no clear fire".
As for the viable insulin-and-cancer link, Harlan said that because a weak association was found, it's definitely an court that needs to be pursued further. But that doesn't mean that anyone should change the way they're managing their diabetes. "Our greatest interest to is that individuals with diabetes might choose not to treat their diabetes with insulin or a nice insulin out of concern for a malignancy.
The risk of diabetes complications is a far greater concern. It's get a kick out of when someone decides to drive across the country because they're afraid to fly. While there is a miniature risk of dying in a plane crash, statistically it's far riskier to drive". The consensus put out is published in the July/August issue of CA: A Cancer Journal for Clinicians.
People with diabetes may have something else to be troubled about - an increased jeopardize of cancer, according to a green consensus report produced by experts recruited jointly by the American Cancer Society and the American Diabetes Association. Diabetes, mostly type 2 diabetes, has been linked to certain cancers, though experts aren't ineluctable if the disease itself leads to the increased risk or if shared risk factors, such as obesity, may be to blame. Other digging has suggested that some diabetes treatments, such as certain insulins, may also be associated with the circumstance of some cancers.
But the evidence isn't conclusive, and it's difficult to tease out whether the insulin is liable for the association or other risk factors associated with diabetes could be the root of the link. "There have been some epidemiological studies that suggest that individuals who are pot-bellied or who have high levels of insulin appear to have an increased prevalence of certain malignancies, but it's a complex edition because the association is not true for all cancers," explained Dr David Harlan, guide of the Diabetes Center of Excellence at the University of Massachusetts Memorial Medical Center in Worcester, and one of the authors of the consensus report. "So, there's some smoke to suggest an linkage - but no clear fire".
As for the viable insulin-and-cancer link, Harlan said that because a weak association was found, it's definitely an court that needs to be pursued further. But that doesn't mean that anyone should change the way they're managing their diabetes. "Our greatest interest to is that individuals with diabetes might choose not to treat their diabetes with insulin or a nice insulin out of concern for a malignancy.
The risk of diabetes complications is a far greater concern. It's get a kick out of when someone decides to drive across the country because they're afraid to fly. While there is a miniature risk of dying in a plane crash, statistically it's far riskier to drive". The consensus put out is published in the July/August issue of CA: A Cancer Journal for Clinicians.
Women Suffer From Rheumatoid Arthritis More Often Than Men
Women Suffer From Rheumatoid Arthritis More Often Than Men.
Rheumatoid arthritis patients can on the whole look out on forward to a much better quality of life today than they did 20 years ago, renewed research suggests. The observation is based on a comparative multi-year tracking of more than 1100 rheumatoid arthritis patients. All had been diagnosed with the often permanently debilitating autoimmune ailment at some point between 1990 and 2011. The reason for the brighter outlook: a combination of better drugs, better performance and mental health therapies, and a greater effort by clinicians to boost patient spirits while encouraging continued somatic activity.
And "Nowadays, besides research on new drug treatments, digging is mainly focused on examining which treatment works best for which patient, so therapy can become more 'tailor-made' and therefore be more effective for the separate patient," said Cecile Overman, the study's lead author. Overman, a doctoral undergraduate in clinical and health psychology at Utrecht University in the Netherlands, expects that in another 20 years, rheumatoid arthritis patients will have the same grandeur of life as anyone else "if the focus on the whole patient - not just the disease, but also the person's lunatic and physical well-being - is maintained and treatment opportunities continue to evolve. The enquiry was released online Dec 3, 2013 in Arthritis Care and Research.
In rheumatoid arthritis, the body's safe system mistakenly attacks the joints, the Arthritis Foundation explains. The resulting redness can damage joints and organs such as the heart. Patients endure sudden flare-ups with warm, swollen joints, pain and fatigue. Currently there is no cure but a classification of drugs can treat symptoms and prevent the condition from getting worse.
Up to 1 percent of the world's residents currently struggles with the condition, according to the World Health Organization. The current study was composed first of all of female rheumatoid arthritis patients (68 percent). Women are more prone to developing the working order than men. Patients ranged in age from 17 to 86, and all were Dutch.
Each was monitored for the sally of disease-related physical and mental health disabilities for anywhere from three to five years following their first diagnosis. Disease activity was also tracked to assess progression. The observed trend: a theatric two-decade drop in physical disabilities. The researchers also saw a decline in the incidence of appetite and depression.
Rheumatoid arthritis patients can on the whole look out on forward to a much better quality of life today than they did 20 years ago, renewed research suggests. The observation is based on a comparative multi-year tracking of more than 1100 rheumatoid arthritis patients. All had been diagnosed with the often permanently debilitating autoimmune ailment at some point between 1990 and 2011. The reason for the brighter outlook: a combination of better drugs, better performance and mental health therapies, and a greater effort by clinicians to boost patient spirits while encouraging continued somatic activity.
And "Nowadays, besides research on new drug treatments, digging is mainly focused on examining which treatment works best for which patient, so therapy can become more 'tailor-made' and therefore be more effective for the separate patient," said Cecile Overman, the study's lead author. Overman, a doctoral undergraduate in clinical and health psychology at Utrecht University in the Netherlands, expects that in another 20 years, rheumatoid arthritis patients will have the same grandeur of life as anyone else "if the focus on the whole patient - not just the disease, but also the person's lunatic and physical well-being - is maintained and treatment opportunities continue to evolve. The enquiry was released online Dec 3, 2013 in Arthritis Care and Research.
In rheumatoid arthritis, the body's safe system mistakenly attacks the joints, the Arthritis Foundation explains. The resulting redness can damage joints and organs such as the heart. Patients endure sudden flare-ups with warm, swollen joints, pain and fatigue. Currently there is no cure but a classification of drugs can treat symptoms and prevent the condition from getting worse.
Up to 1 percent of the world's residents currently struggles with the condition, according to the World Health Organization. The current study was composed first of all of female rheumatoid arthritis patients (68 percent). Women are more prone to developing the working order than men. Patients ranged in age from 17 to 86, and all were Dutch.
Each was monitored for the sally of disease-related physical and mental health disabilities for anywhere from three to five years following their first diagnosis. Disease activity was also tracked to assess progression. The observed trend: a theatric two-decade drop in physical disabilities. The researchers also saw a decline in the incidence of appetite and depression.
Subscribe to:
Posts (Atom)